Evelo Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Evelo Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2020 to Q3 2023.
  • Evelo Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $0 -$7.4M -100% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $5.77M -$2.15M -27.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $6.32M -$2.1M -24.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $6.87M -$2.04M -22.9% Dec 31, 2022 10-Q 2023-11-09
Q3 2022 $7.4M -$1.99M -21.2% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $7.92M -$1.94M -19.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $8.42M -$1.89M -18.4% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $8.91M -$1.85M -17.2% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $9.39M -$1.8M -16.1% Sep 30, 2021 10-Q/A 2021-10-29
Q2 2021 $9.86M -$1.76M -15.2% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $10.3M -$1.79M -14.8% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $10.8M Dec 31, 2020 10-K 2022-03-24
Q3 2020 $11.2M Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $11.6M Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $12.1M Mar 31, 2020 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.